We are live on ! Find out more
NAVB

Navidea Biopharmaceuticals Inc.
NAVB

Delisted

NAVB was delisted on the 5th of October, 2023.

Back to rankings

75 hedge funds and large institutions have $87.1M invested in Navidea Biopharmaceuticals Inc. in 2013 Q2 according to their latest regulatory filings, with 75 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

101% more call options, than puts

Call options by funds: $3.51M | Put options by funds: $1.74M

Holders
75
Holders Change
+75
Holders Change %
–
% of All Funds
2.45%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
75
Increased
–
Reduced
–
Closed
–
Calls
$3.51M
Puts
$1.74M
Net Calls
+$1.76M
Net Calls Change
+$1.76M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
PM
1
Platinum Management
New York
$24.5M +$23M +459,726 New
Vanguard Group
2
Vanguard Group
Pennsylvania
$8.35M +$7.81M +156,442 New
BFA
3
BlackRock Fund Advisors
California
$8M +$7.48M +149,869 New
BIT
4
BlackRock Institutional Trust
California
$5.8M +$5.43M +108,678 New
JP Morgan Chase
5
JP Morgan Chase
New York
$5.26M +$4.91M +98,425 New
Nomura Holdings
6
Nomura Holdings
Japan
$4.6M +$4.33M +86,803 New
State Street
7
State Street
Massachusetts
$4.31M +$4.03M +80,619 New
Northern Trust
8
Northern Trust
Illinois
$4.19M +$3.92M +78,419 New
CA
9
Commerzbank Aktiengesellschaft
Germany
$2.73M +$2.55M +51,070 New
TCM
10
Tang Capital Management
California
$2.32M +$2.17M +43,404 New
Bank of New York Mellon
11
Bank of New York Mellon
New York
$1.69M +$1.58M +31,717 New
Geode Capital Management
12
Geode Capital Management
Massachusetts
$1.35M +$1.27M +25,381 New
TCIM
13
TIAA CREF Investment Management
New York
$1.28M +$1.2M +24,035 New
Susquehanna International Group
14
Susquehanna International Group
Pennsylvania
$944K +$882K +17,672 New
California Public Employees Retirement System
15
California Public Employees Retirement System
California
$878K +$821K +16,440 New
BIM
16
BlackRock Investment Management
Delaware
$878K +$821K +16,441 New
Deutsche Bank
17
Deutsche Bank
Germany
$808K +$757K +15,163 New
Charles Schwab
18
Charles Schwab
California
$629K +$572K +11,463 New
DA
19
DSC Advisors
Illinois
$627K +$587K +11,750 New
Morgan Stanley
20
Morgan Stanley
New York
$619K +$579K +11,597 New
California State Teachers Retirement System (CalSTRS)
21
California State Teachers Retirement System (CalSTRS)
California
$556K +$520K +10,420 New
AllianceBernstein
22
AllianceBernstein
Tennessee
$428K +$400K +8,012 New
TA
23
Teachers Advisors
New York
$394K +$369K +7,387 New
MC
24
Miles Capital
Iowa
$358K +$335K +6,707 New
Swiss National Bank
25
Swiss National Bank
Switzerland
$316K +$295K +5,915 New
1
2 3

NAVB Hedge Fund Activity: Q2 2013 in Review

75 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Navidea Biopharmaceuticals Inc. (NAVB) for Q2 2013, worth a combined $87.1M.

Buyers outnumbered sellers: 75 funds opened new NAVB positions and 0 closed out — a net gain of 75 holders — while 0 added to existing stakes and 0 trimmed.

  • 75 institutional investors held Navidea Biopharmaceuticals Inc. (NAVB) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $87.1M of Navidea Biopharmaceuticals Inc. stock for Q2 2013.
  • 75 funds opened new Navidea Biopharmaceuticals Inc. positions in Q2 2013 and 0 closed out, a net change of +75 holders.

Based on aggregated 13F filings for Q2 2013.